Aims and objectives of service Clause Samples

Aims and objectives of service. 1. To improve the mental and emotional health and wellbeing of children with autism, through training and early intervention with parents and professionals. 2. To raise the expectations of parents, carers and professionals who will be working with children with autism and help them to realise the child’s full potential. 3. The programme will help families to:  Understand their child’s autism  Better cope with their autistic child’s behaviour  Structure interactions to enable communication to develop  Develop strategies to pre-empt challenging behaviours and deal with those that might occur  Improve the quality of family life resulting in the prevention of family breakdown

Aims and objectives of service. To provide a low threshold entry to Tier 4 treatment for the substance misusers in crisis. Tier 4 interventions are described in ‘Models of Care’ as including residential specialised drug treatment, which is care planned and

Aims and objectives of service. To optimise patient vision and minimise avoidable visual disability, mortality and other morbidity by providing high quality care that meets the needs of adults with ophthalmic problems. • To provide the investigation and management of rare and/or complex visual, ocular and ocular adnexal disorders. • To ensure that there is a sufficient, skilled and competent multi-disciplinary workforce to manage adults with ophthalmic disorders. • To ensure that adults have their ophthalmic and general healthcare, education and social care plans coordinated. • To ensure patients are treated in line with national guidelines and agree local pathways. Treatment is predominately delivered in an outpatient setting and where appropriate as an inpatient (▇▇▇▇ or day unit as required), with carefully monitored shared care arrangements in place with referring clinicians. There were 5.95 million attendances at English NHS Ophthalmology departments in 2009-10.1.69 million of these (28%) were first attendances. Specialised services are required to keep data to ensure coding is accurate. The service will deliver the aim to optimise vision and prevent avoidable visual disability of ophthalmic (eye and vision) disorders by: • making timely and accurate diagnoses • timely investigation and management • providing high quality proactive treatment and care • providing appropriate counselling and psychological support to patients • support patients with poor vision • support patients with long term conditions • support patients to manage their condition independently • ensuring effective communication between patients and service providers. • providing a personal service, sensitive to the physical, psychological and emotional needs of the patient. • provide advice, when appropriate, on Letter of Vision Impairment (LVI), Referral of Vision Impairment (RVI) and Certificate of Vision Impairment (CVI) Clinically this service covers all ophthalmic subspecialties and is therefore by definition heterogeneous

Aims and objectives of service. The key aims of the service is to:  To improve the health outcomes for children and young people who have a neurodisability  Early, appropriate and cost – effective  Increase the focus on improving children‘s lives by ensuring that professional work together across organisational boundaries to meet the needs of the young people. The key objectives are to:  To provide a high quality, timely consultant led medical service for children and young people with complex neurodisability for children and young people under the age of 19 (or during transition into adulthood).  Through the provision of a multi-disciplinary neurodisability service, children young

Aims and objectives of service. The aim of the supranetwork penile cancer service is to deliver high-quality multidisciplinary holistic care aimed at increasing survival while maintaining sexual and urinary function, and quality of life. It also ensures ready and timely access to appropriate supportive care for patients, their relatives and carers. The service will be delivered through a supra-network penile multidisciplinary team, with some elements,(e.g.radiotherapy/chemotherapy) delivered at a local level depending upon the needs of the patient. All patients with penile cancer, both new and existing, should be managed by specialist multidisciplinary urological cancer teams. These teams should be established in large hospitals or cancer centres. All operations carried out by the penile cancer team should be carried out in a single hospital, which should also provide post-operative care and host the supranetwork multidisciplinary team (MDT) meetings. Documented clinical policies for referral and treatment should be agreed between cancer leads in primary care and lead clinicians representing urological, oncology and palliative care services throughout the network, and signed off by the lead clinician for the network. Effective systems will be required to ensure rapid communication and efficient co- ordination between teams. Patients with penile cancer should be managed by specialist penile cancer teams working at the supranetwork level. Such teams should serve up to four networks, with a combined population base of at least four million. These teams should liaise closely and regularly with local urological cancer teams, who themselves will be responsible for some aspects of the diagnosis and treatment of these cancers. The service is required to agree the following areas with their local cancer networks: • Service configuration and population coverage • Referral criteria, clinical protocols (including referral and management of post- operative patients, emergency protocols, and pathways that enable rapid access for treatment), network policies (including local surgical policies) and treatment pathways. • Engagement with the local network groups and National Cancer Peer Review for penile cancers under urological tumours. The overall objectives of the services are: • To provide care with a patient- and family-centred focus to deliver the best possible patient experience, contributing to and learning from patient experience and outcome measures. • To provide an exemplary and comprehensive s...

Aims and objectives of service.  To provide alternative options to facilitate stopping smoking;  To reduce smoking related illnesses and deaths by supporting people to give up smoking;  To improve the health of the North Lincolnshire population by reducing exposure to passive smoke;  To facilitate behaviour change as a means to improving health and well-being.

Aims and objectives of service. The aim of the service is to increase access to sexual health services in Kirklees in order to reduce unintended pregnancies and improve sexual health. In addition the services will increase knowledge of the consequences of risky sexual behaviour by providing information and advice as appropriate on sexual health issues including STIs, avoiding unplanned pregnancy, contraception and delaying sex (as appropriate). The service will also improve awareness of the range of sexual health services available in the area. • Specifically, the services will comprise: a consultation, information and advice, signposting to other services, provision of emergency hormonal contraception (EHC), pregnancy testing, Chlamydia screening and provision of condoms. • Females aged 13 and over who present within 120 hours of unprotected sexual intercourse will be provided with emergency hormonal contraception (subject to circumstances) free of charge • The Contract allows the Provider to supply Levonorgestrol or Ulispristal emergency hormonal contraception to appropriate clients in line with relevant guidance and patient group directions, by accredited pharmacists from the accredited Provider. • Increase the Public Health role of the community pharmacist and promote multidisciplinary working in relation to sexual health.

Aims and objectives of service. The National Insulin Resistant Diabetes Service provides a multidisciplinary outpatient clinic at Cambridge University Hospitals NHS Foundation Trust (CUH) plus inpatient stays for initiation of therapy when indicated. The aim of the service is to provide diagnostic, therapeutic and educational support for both patients and their local clinical carers, and to establish and disseminate evidence-based recommendations for the therapy of this severe group of conditions. The service is targeted at patients with lipodystrophy and/or extreme insulin resistance as defined below (in 2.1). These are very rare but metabolically devastating disorders associated with significant long-term morbidity and mortality. The purpose of the service is to improve outcomes for these patients through the following mechanisms: • by providing a precise diagnosis wherever possible • by the provision of targeted specialist delivered treatment interventions including both dietary and pharmacological therapies • by educating patients, their relatives (where this is appropriate) and local health carers • by raising the profile of severe insulin resistance/lipodystrophy as a clinical problem in order to improve access to optimal care for affected patients. Objectives and expected outcomes Diagnosis Accurate clinical assessment is an essential step to putting the correct management strategies in place early for this group of patients. This requires close links to clinical biochemistry, molecular genetics and radiology services, to provide a complete, integrated package of clinical, biochemical and radiological evaluation as well as definitive molecular genetic diagnosis where appropriate. Objective 1 • To provide a specific diagnosis to all patients with lipodystrophy/severe insulin resistance. This is not currently possible as the genetic basis of several of the disease

Aims and objectives of service. The aim of the service will be to provide a specialist service for patients with Neuromyelitis Optica (NMO) and NMO spectrum disorders.. The NMO service will offer; a rapid access diagnostic service; patient and clinical advice; supervision of clinical management in collaboration with the local referrer and for severe and acute cases provide in-patient treatment. This multi-disciplinary service will encompass all aspects of diagnosis and treatment recognising the complementary strengths and utilising the specialist clinical and laboratory skills available in conjunction with local services. The diagnostic skills will include imaging, (the atypical and variable appearances will require expert neuroradiology input), NMO antibody testing at the Oxford unit, and histology (which will require expert neuropathology experience). Treatment includes : • advice on immunosuppressive therapy and its monitoring • delivering aggressive therapies in severe cases where local centres lack experience • providing paediatric input for children • physiotherapy input to assess disability and advice on a local rehabilitation programme • maintaining a phone help line. Many neurologists do not have experience or the clinical facilities to supervise aggressive immunosuppression. However early diagnosis and appropriate treatment of NMO will prevent irreversible and severe disability. A UK specialist NMO service aims to reduce mis-diagnoses and inappropriate treatment. The NMO service would thus produce national guidelines for UK neurologists for early referral of potential patients to maximise benefits Additionally, as with all rare conditions, the added value for patient’s lies in being seen by a team of specialists (not only doctors, but specialist nurses, physios etc) who understand their condition and can advise on prognosis and rehabilitation schedules. Concentrating patients with a rare disorder through a specialist service improves the ability to recruit into clinical trials, which are needed to provide evidence for the most effective and cost-effective treatments.